Imperagen

Imperagen

BiotechManchester, United Kingdom

Imperagen is a biotech company focused on enzyme engineering, utilizing quantum physics and AI to enhance the speed and efficiency of enzyme development. The company aims to revolutionize the traditional trial-and-error methods in enzyme engineering, making the process faster and more commercially viable for various industries, including pharmaceuticals and agriculture.

$6.7M · SeedVisit website ↗

Funding history

  1. $6.7MSeed2026-05-21
    Source: news.google.com

Founder

Dr. Andrew Currin, Dr. Tim Eyes, Dr. Andy Almond
Dr. Andrew Currin, Dr. Tim Eyes, Dr. Andy Almond
Co-founders

Investors in Imperagen

Backers from this company's tracked funding rounds.

  • PXN Ventures
  • IQ Capital
  • Northern Gritstone

Related on Datapile